Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New rhodanine carboxylic acid derivatives useful for bone disorders

May 2, 2000

Microbial metabolite Sch-351448 acts as a selective LDL receptor promoter activator

April 28, 2000

Lantus approved by FDA for type I and II diabetes

April 27, 2000

Orion acquires worldwide rights to Nestorone as hormone replacement therapy

April 26, 2000

Sankyo acquires expanded marketing rights to new antihyperlipidemic agent

April 26, 2000

Inhibitors of PTP1B in early development at Merck

April 26, 2000

Basulin completes proof-of-principle study

April 25, 2000

DepoMed reports phase I results for Metformin GR

April 24, 2000

Raloxifene shows good uterine safety profile

April 24, 2000

Humalog now available in Europe to treat children with diabetes

April 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...